Cladribine Based Salvage Chemotherapy
A Phase II Study of the Efficacy and Pharmacogenomics of Cladribine-based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 90 patients (estimated)
- Sponsors
- Medical College of Wisconsin
- Tags
- Chemotherapy, Steroid
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1492
- NCT Identifier
- NCT03150004
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.